ADAP Message Board Post 9876940 | Adaptimmune Therapeutics...
home / stock / adap / adap message board
kunaladitya
(investorshub)
Posted on: Oct/26/2021 21:10:05
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166521544
New preclinical data (Noile-Immune Bio's PRIME tech) https://mct.aacrjournals.o
News, Short Squeeze, Breakout and More Instantly...
Adaptimmune Therapeutics plc Company Name:
ADAP Stock Symbol:
Market:
Adaptimmune Therapeutics plc Website:
-
Overall response rate of 40% consistent across sarcoma indications; median duration of response ~11 months with patients still in response at time of analysis Interim analysis data reinforces the potential of lete-cel to bolster Adaptimmune's sarcoma franchise by expanding addressable sarcoma pa...
-
2024-05-31 16:15:02 ET Wells Fargo analyst issues EQUAL-WEIGHT recommendation for ADAP on May 31, 2024 02:43PM ET. The previous analyst recommendation was Equal-Weight. ADAP was trading at $1.135 at issue of the analyst recommendation. The overall analyst consensus : BUY...